INTRODUCTION: Machine learning models were used to discover novel disease trajectories for autosomal dominant Alzheimer's disease. METHODS: Longitudinal structural magnetic resonance imaging, amyloid positron emission tomography (PET), and fluorodeoxyglucose PET were acquired in 131 mutation carriers and 74 non-carriers from the Dominantly Inherited Alzheimer Network; the groups were matched for age, education, sex, and apolipoprotein ε4 (APOE ε4). A deep neural network was trained to predict disease progression for each modality. Relief algorithms identified the strongest predictors of mutation status. RESULTS: The Relief algorithm identified the caudate, cingulate, and precuneus as the strongest predictors among all modalities. The model yielded accurate results for predicting future Pittsburgh compound B (R2 = 0.95), fluorodeoxyglucose (R2 = 0.93), and atrophy (R2 = 0.95) in mutation carriers compared to non-carriers. DISCUSSION: Results suggest a sigmoidal trajectory for amyloid, a biphasic response for metabolism, and a gradual decrease in volume, with disease progression primarily in subcortical, middle frontal, and posterior parietal regions.
INTRODUCTION: Machine learning models were used to discover novel disease trajectories for autosomal dominant Alzheimer's disease. METHODS: Longitudinal structural magnetic resonance imaging, amyloid positron emission tomography (PET), and fluorodeoxyglucose PET were acquired in 131 mutation carriers and 74 non-carriers from the Dominantly Inherited Alzheimer Network; the groups were matched for age, education, sex, and apolipoprotein ε4 (APOE ε4). A deep neural network was trained to predict disease progression for each modality. Relief algorithms identified the strongest predictors of mutation status. RESULTS: The Relief algorithm identified the caudate, cingulate, and precuneus as the strongest predictors among all modalities. The model yielded accurate results for predicting future Pittsburgh compound B (R2 = 0.95), fluorodeoxyglucose (R2 = 0.93), and atrophy (R2 = 0.95) in mutation carriers compared to non-carriers. DISCUSSION: Results suggest a sigmoidal trajectory for amyloid, a biphasic response for metabolism, and a gradual decrease in volume, with disease progression primarily in subcortical, middle frontal, and posterior parietal regions.
Authors: Eric McDade; Guoqiao Wang; Brian A Gordon; Jason Hassenstab; Tammie L S Benzinger; Virginia Buckles; Anne M Fagan; David M Holtzman; Nigel J Cairns; Alison M Goate; Daniel S Marcus; John C Morris; Katrina Paumier; Chengjie Xiong; Ricardo Allegri; Sarah B Berman; William Klunk; James Noble; John Ringman; Bernardino Ghetti; Martin Farlow; Reisa A Sperling; Jasmeer Chhatwal; Stephen Salloway; Neill R Graff-Radford; Peter R Schofield; Colin Masters; Martin N Rossor; Nick C Fox; Johannes Levin; Mathias Jucker; Randall J Bateman Journal: Neurology Date: 2018-09-14 Impact factor: 9.910
Authors: Lyduine E Collij; Fiona Heeman; Joost P A Kuijer; Rik Ossenkoppele; Marije R Benedictus; Christiane Möller; Sander C J Verfaillie; Ernesto J Sanz-Arigita; Bart N M van Berckel; Wiesje M van der Flier; Philip Scheltens; Frederik Barkhof; Alle Meije Wink Journal: Radiology Date: 2016-07-06 Impact factor: 11.105
Authors: Randall J Bateman; Chengjie Xiong; Tammie L S Benzinger; Anne M Fagan; Alison Goate; Nick C Fox; Daniel S Marcus; Nigel J Cairns; Xianyun Xie; Tyler M Blazey; David M Holtzman; Anna Santacruz; Virginia Buckles; Angela Oliver; Krista Moulder; Paul S Aisen; Bernardino Ghetti; William E Klunk; Eric McDade; Ralph N Martins; Colin L Masters; Richard Mayeux; John M Ringman; Martin N Rossor; Peter R Schofield; Reisa A Sperling; Stephen Salloway; John C Morris Journal: N Engl J Med Date: 2012-07-11 Impact factor: 91.245
Authors: Randall J Bateman; Paul S Aisen; Bart De Strooper; Nick C Fox; Cynthia A Lemere; John M Ringman; Stephen Salloway; Reisa A Sperling; Manfred Windisch; Chengjie Xiong Journal: Alzheimers Res Ther Date: 2011-01-06 Impact factor: 6.982
Authors: Patrick H Luckett; Charlie Chen; Brian A Gordon; Julie Wisch; Sarah B Berman; Jasmeer P Chhatwal; Carlos Cruchaga; Anne M Fagan; Martin R Farlow; Nick C Fox; Mathias Jucker; Johannes Levin; Colin L Masters; Hiroshi Mori; James M Noble; Stephen Salloway; Peter R Schofield; Adam M Brickman; William S Brooks; David M Cash; Michael J Fulham; Bernardino Ghetti; Clifford R Jack; Jonathan Vöglein; William E Klunk; Robert Koeppe; Yi Su; Michael Weiner; Qing Wang; Daniel Marcus; Deborah Koudelis; Nelly Joseph-Mathurin; Lisa Cash; Russ Hornbeck; Chengjie Xiong; Richard J Perrin; Celeste M Karch; Jason Hassenstab; Eric McDade; John C Morris; Tammie L S Benzinger; Randall J Bateman; Beau M Ances Journal: Alzheimers Dement Date: 2022-04-01 Impact factor: 16.655
Authors: Arvind Caprihan; Rajikha Raja; Laura J Hillmer; Erik Barry Erhardt; Jill Prestopnik; Jeffrey Thompson; John C Adair; Janice E Knoefel; Gary A Rosenberg Journal: Cereb Circ Cogn Behav Date: 2021-04-02